The effect of BK channel activators in both melanoma and pancreatic duct adenocarcinoma has not been evaluated thus far, and indeed the present investigation aims to clarify the Yin and Yang role of BK channel in these types of cancer. Here, KCNMA1 is linked to pancreatic ductal adenocarcinoma.